Overview of Congenital Hepatic Fibrosis in Pediatrics: A Review

Ahmed Abdelsamie Fadl *

Doctor Samir Abbas Hospital, Saudi Arabia and Department of pediatrics Alazhar Unversity Hospitals, Cairo, Egypt.

Sarah jamal almujil

KAUH, Saudi Arabia.

Ahmed Saeed S. Banheem

King Abdullah Medical Complex Jeddah, Saudi Arabia.

Nasser Naif Alsuhaymi

Al-Rayan Colleges, Medina, Saudi Arabia.

Mansour Hemaid Alhelali

Medical Rehabilitation Hospital, Saudi Arabia.

Dhiyaa Hassan A. Aldukhi

Medical Graduate, Saudi Arabia.

Khalil Rafed B. Alsaedi

Medical Rehabilitation Hospital, Saudi Arabia.

Naif Mohammed Al-Wagdani

King Abdulaziz Hospital, Jeddah, Saudi Arabia.

Ebtesam Ali S. Almadi

Qassim University, Saudi Arabia.

Khalid Mohammed A. Aladhadh

King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.

Fahad Amrh AlAjmi

Farwaniyah Hospital, Kuwait.

*Author to whom correspondence should be addressed.


Abstract

Congenital hepatic fibrosis is a rare developmental illness caused by a ductal plate malformation, often known as ciliopathy or fibrocystic liver disease. Hepatosplenomegaly and portal hypertension are two symptoms. The disease affects 1/10000–20000 people. frequently associated with a variety of illnesses caused by genetic abnormalities, such as autosomal recessive polycystic kidney disease (ARPKD) and Caroli syndrome. There hasn't been a way to stop or reverse the progression of congenital hepatic fibrosis until now. Clinical trials of anti-fibrotic medicines such as colchicine, interferon gamma, angiotensin II receptor blockers, pirfenidone, and ursodeoxycholic acid found no significant benefit. The only known cure for CHF is liver transplantation, which is recommended when the condition has progressed to the point when symptoms of liver failure have appeared. In this article we will be making overview of the disease. It’s symptoms and diagnosis, different treatment method, and we will compare some of the articles published about the disease.

Keywords: Congenital hepatic fibrosis, genetic abnormalities, autosomal recessive polycystic kidney disease


How to Cite

Fadl, Ahmed Abdelsamie, Sarah jamal almujil, Ahmed Saeed S. Banheem, Nasser Naif Alsuhaymi, Mansour Hemaid Alhelali, Dhiyaa Hassan A. Aldukhi, Khalil Rafed B. Alsaedi, et al. 2021. “Overview of Congenital Hepatic Fibrosis in Pediatrics: A Review”. Journal of Pharmaceutical Research International 33 (60A):470-77. https://doi.org/10.9734/jpri/2021/v33i60A34507.

Downloads

Download data is not yet available.